Media Center

Sandoz donates 25,000 units of benzathine penicillin to rheumatic heart disease study in Zambia

August 29, 2014 - Life-saving medicines from Sandoz have arrived at the University Teaching Hospital in Lusaka, Zambia. The donated units of benzathine penicillin will support a new rheumatic heart disease study by the Novartis Institutes for BioMedical Research (NIBR). Penicillin prophylaxis is the only way by which new cases of rheumatic heart disease can be prevented.
Read more.